Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Unlocking the Potential of Enovix (ENVX)

Enovix shares fell by -1.4% during the day's morning session, and are now trading at a price of $15.71. Is it time to buy the dip? To better answer that question, it's essential to check if the market is valuing the company's shares fairly in terms of its earnings and equity levels.

Enovix's P/B and P/E Ratios Are Higher Than Average:

Enovix Corporation designs, develops, and manufactures lithium-ion battery cells in the United States and internationally. The company belongs to the Industrials sector, which has an average price to earnings (P/E) ratio of 24.03 and an average price to book (P/B) ratio of 2.89. In contrast, Enovix has a trailing 12 month P/E ratio of -14.1 and a P/B ratio of 12.8.

Enovix has moved -19.8% over the last year compared to 10.6% for the S&P 500 — a difference of -30.4%. Enovix has a 52 week high of $18.68 and a 52 week low of $5.27.

Increasing Revenues but Narrowing Margins:

2020 2022 2023 2024
Revenue (k) $3,375 n/a $6,202 $23,074
Net Margins -395.0% n/a -832.0% -963.0%
Net Income (k) -$13,342 -$125,874 -$51,622 -$222,241
Net Interest Expense (k) -$107 -$187 $5,231 $18,743
Depreciation & Amort. (k) $600 $1,515 $7,972 $44,961
Diluted Shares (k) 80,367 153,332 159,576 175,038
Earnings Per Share -$0.49 -$1.07 -$0.82 -$1.27
EPS Growth n/a -118.37% 23.36% -54.88%
Free Cash Flow (k) -$12,549 -$94,890 -$118,952 -$184,821
CAPEX (k) $8,030 $43,584 $36,212 $76,188
Current Ratio 3.04 20.28 5.3 5.49
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS